Treatment of anemia in myelodysplastic syndromes

被引：0
|
作者：
Fenaux, Pierre [1 ]
Kelaidi, Chairikleia [1 ]
机构：
[1] Univ Paris XIII, AP HP, Hop Avicenne, Serv Hematol Clin, 125 Rue Stalingrad, F-93009 Bobigny, France
来源：
HEMATOLOGIE | 2006年 / 12卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：15 / 21
页数：7
相关论文
共 50 条
  • [31] Erythropoiesis-stimulating agents in the treatment of anemia in myelodysplastic syndromes: a meta-analysis
    Victor Moyo
    Patrick Lefebvre
    Mei Sheng Duh
    Behin Yektashenas
    Suneel Mundle
    Annals of Hematology, 2008, 87 : 527 - 536
  • [32] Activity of Luspatercept and ESAs Combination for Treatment of Anemia in Lower-Risk Myelodysplastic Syndromes
    Al Ali, Najla
    Luis, Aguirre
    Onyee, Chan
    Kuykendall, Andrew
    Lancet, Jeffrey
    Padron, Eric
    Sallman, David
    Komrokji, Rami
    CLINICAL LYMPHOMA MYELOMA & LEUKEMIA, 2023, 23 : S363 - S364
  • [33] Luspatercept: A New Tool for the Treatment of Anemia Related to β-Thalassemia, Myelodysplastic Syndromes and Primary Myelofibrosis
    Hatzimichael, Eleftheria
    Timotheatou, Despoina
    Koumpis, Epameinondas
    Benetatos, Leonidas
    Makis, Alexandros
    DISEASES, 2022, 10 (04)
  • [34] SUCCESSFUL TREATMENT WITH DANAZOL FOR MYELODYSPLASTIC SYNDROMES AND APLASTIC ANEMIA REFRACTORY OR INELIGIBLE TO STANDARD THERAPY
    Schieppati, F.
    Pelizzari, A. M.
    Borlenghi, E.
    D'Adda, M.
    Cerqui, E.
    Marocolo, D.
    Rossi, G.
    HAEMATOLOGICA, 2017, 102 : 488 - 489
  • [35] Activity of luspatercept and ESAs combination for treatment of anemia in lower-risk myelodysplastic syndromes
    Komrokji, Rami S.
    Aguirre, Luis E.
    Al Ali, Najla H.
    Chan, Onyee
    Xie, Zhuoer
    Kuykendall, Andrew
    Sweet, Kendra
    Lancet, Jeffrey E.
    Padron, Eric
    Sallman, David A.
    BLOOD ADVANCES, 2023, 7 (14) : 3677 - 3679
  • [36] Efficacy and safety of CC5013 for treatment of anemia in patients with myelodysplastic syndromes (MDS).
    List, AF
    Kurtin, S
    Glinsmann-Gibson, B
    Bellamy, W
    Buresh, A
    Mahadevan, D
    Rimsza, L
    Waddelton, D
    Knight, RD
    BLOOD, 2003, 102 (11) : 184A - 184A
  • [37] Erythropoiesis-stimulating agents in the treatment of anemia in myelodysplastic syndromes: a meta-analysis
    Moyo, Victor
    Lefebvre, Patrick
    Duh, Mei Sheng
    Yektashenas, Behin
    Mundle, Suneel
    ANNALS OF HEMATOLOGY, 2008, 87 (07) : 527 - 536
  • [38] DANAZOL IN THE TREATMENT OF MYELODYSPLASTIC SYNDROMES
    BUZAID, AC
    GAREWAL, HS
    LIPPMAN, SM
    DURIE, BGM
    KATAKKAR, SB
    GREENBERG, BR
    EUROPEAN JOURNAL OF HAEMATOLOGY, 1987, 39 (04) : 346 - 348
  • [39] Clofarabine in the treatment of myelodysplastic syndromes
    Bryan, Jeffrey
    Kantarjian, Hagop
    Prescott, Hillary
    Jabbour, Elias
    EXPERT OPINION ON INVESTIGATIONAL DRUGS, 2014, 23 (02) : 255 - 263
  • [40] TREATMENT OF MYELODYSPLASTIC SYNDROMES WITH DANAZOL
    AVILES, A
    GARCIA, LD
    ROMERO, N
    TRIPP, F
    GONZALEZLLAVEN, J
    ARCHIVOS DE INVESTIGACION MEDICA, 1988, 19 (01): : 73 - 77
12345